Telix Pharmaceuticals Names Anne Whitaker as Non-Executive Director

Benzinga Press Release

Anne Whitaker Appointed as Non-Executive Director

LONDON, April 25, 2022 - Anne Whitaker has been appointed as a non-executive director of the company, effective immediately.

Whitaker brings a wealth of experience in the industry, having spent over 20 years in various leadership roles. Her most recent position was as the CEO of a leading company, where she was responsible for overseeing the overall strategy and direction of the organization.

"We are thrilled to welcome Anne to our board of directors," said a spokesperson for the company. "Her extensive experience and expertise will be invaluable in helping us achieve our goals and drive growth."

Whitaker's appointment comes as the company continues to expand its operations and explore new opportunities. Her addition to the board will help the company navigate its next phase of growth and development.

"I am honored to be joining the board of directors and look forward to contributing my skills and experience to help the company achieve its objectives," said Whitaker.

About Anne Whitaker Anne Whitaker is a seasoned executive with over 20 years of experience in the industry. Prior to her appointment as CEO, she held various leadership roles, including Director of Operations and Chief Operating Officer. She has a proven track record of driving growth and improving operational efficiency.

About the Company The company is a leading player in the industry, with a strong reputation for delivering high-quality products and services. The company is committed to innovation, customer satisfaction, and community involvement.

Contact: [Name] [Email] [Phone]